Cargando…
Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer’s Disease: A Protocol for Multicenter Phase II Clinical Trial
BACKGROUND: Alzheimer’s disease (AD), the most common cause of dementia, is a neurodegenerative disease resulting from extracellular and intracellular deposits of amyloid-β (Aβ) and neurofibrillary tangles in the brain. Although many clinical studies evaluating pharmacological approaches have been c...
Autores principales: | Kim, Dong-Yun, Kim, Jae Sik, Seo, Young-Seok, Park, Woo-Yoon, Kim, Byoung Hyuck, Hong, Eun-Hee, Kim, Ji Young, Cho, Seong-Jun, Rhee, Hak Young, Kim, Aryun, Kim, Keun You, Oh, Dae Jong, Chung, Weon Kuu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578208/ https://www.ncbi.nlm.nih.gov/pubmed/37638435 http://dx.doi.org/10.3233/JAD-230241 |
Ejemplares similares
-
Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer’s Disease Dementia Patients(1)
por: Chung, Mijoo, et al.
Publicado: (2021) -
The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
por: Kim, Aryun, et al.
Publicado: (2023) -
Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer’s Disease
por: Kim, Sujin, et al.
Publicado: (2020) -
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial
por: Cho, Eun Joo, et al.
Publicado: (2023) -
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
por: Yoon, Wan-Soo, et al.
Publicado: (2023)